Literature DB >> 20299522

Pandemic influenza A (H1N1) virus infections in children with sickle cell disease.

Baba Inusa, Mark Zuckerman, Nimze Gadong, Michele Afif, Sarah Arnott, Paul Heath, Grant Marais, Paula Robertson, Helen Payne, Olu Wilkey, David C Rees.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20299522     DOI： 10.1182/blood-2009-12-260836

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  16 in total

1.  The impact of the 2009 H1N1 influenza pandemic on pediatric patients with sickle cell disease.

Authors:  Alex George; Jennifer Benton; Jesse Pratt; Mi-Ok Kim; Karen A Kalinyak; Theodosia A Kalfa; Clinton H Joiner
Journal:  Pediatr Blood Cancer       Date:  2011-02-25       Impact factor: 3.167

2.  Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell disease.

Authors:  John J Strouse; Megan E Reller; David G Bundy; Martha Amoako; Maria Cancio; Rachel N Han; Alexandra Valsamakis; James F Casella
Journal:  Blood       Date:  2010-07-23       Impact factor: 22.113

3.  Respiratory syncytial virus and seasonal influenza cause similar illnesses in children with sickle cell disease.

Authors:  Sara Christina Sadreameli; Megan E Reller; David G Bundy; James F Casella; John J Strouse
Journal:  Pediatr Blood Cancer       Date:  2014-01-31       Impact factor: 3.167

4.  Influenza vaccine effectiveness and disease burden in children and adolescents with sickle cell disease: 2012-2017.

Authors:  Carol M Kao; Kristina Lai; John M McAteer; Mohnd Elmontser; Elizabeth M Quincer; Marianne E M Yee; Ashley Tippet; Robert C Jerris; Peter A Lane; Evan J Anderson; Nitya Bakshi; Inci Yildirim
Journal:  Pediatr Blood Cancer       Date:  2020-05-29       Impact factor: 3.167

5.  Patients Hospitalized with pH1N1 Influenza in an Academic Community Medical Center.

Authors:  Hagit Bergman; Lawrence L Livornese; Suryaprakash Sambhara; Jerome Santoro; Scott K Dessain
Journal:  Open Respir Med J       Date:  2011-06-20

Review 6.  Potential Impact of Co-Infections and Co-Morbidities Prevalent in Africa on Influenza Severity and Frequency: A Systematic Review.

Authors:  Adam L Cohen; Meredith McMorrow; Sibongile Walaza; Cheryl Cohen; Stefano Tempia; Marissa Alexander-Scott; Marc-Alain Widdowson
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

7.  Vascular Permeability Drives Susceptibility to Influenza Infection in a Murine Model of Sickle Cell Disease.

Authors:  Erik A Karlsson; Thomas H Oguin; Victoria Meliopoulos; Amy Iverson; Alexandria Broadnax; Sun-Woo Yoon; Tamara Pestina; Paul Thomas; Richard Webby; Stacey Schultz-Cherry; Jason W Rosch
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

8.  Prognosis of patients with sickle cell disease and COVID-19: a French experience.

Authors:  Jean-Benoît Arlet; Gonzalo de Luna; Djamal Khimoud; Marie-Hélène Odièvre; Mariane de Montalembert; Laure Joseph; Christelle Chantalat-Auger; Edouard Flamarion; Pablo Bartolucci; François Lionnet; Sebastien Monnier; Cécile Guillaumat; Aline Santin
Journal:  Lancet Haematol       Date:  2020-06-18       Impact factor: 18.959

9.  Alteration of humoral, cellular and cytokine immune response to inactivated influenza vaccine in patients with Sickle Cell Disease.

Authors:  Carole Nagant; Cyril Barbezange; Laurence Dedeken; Tatiana Besse-Hammer; Isabelle Thomas; Bhavna Mahadeb; André Efira; Alice Ferster; Francis Corazza
Journal:  PLoS One       Date:  2019-10-10       Impact factor: 3.240

10.  Effects of vaccines in patients with sickle cell disease: a systematic review protocol.

Authors:  Alison Beriliy Wiyeh; Leila Hussein Abdullahi; Ambroise Wonkam; Charles Shey Wiysonge; Mamadou Kaba
Journal:  BMJ Open       Date:  2018-03-25       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.